MedTrace Logo

Progressive Web App About Individualized Patient Decision Aid for NSCLC Stage I-II

NCT04375566 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2021-08-25

No results posted yet for this study

Summary

Studies indicate that the majority of early-stage non-small cell lung cancer (NSCLC) patients find it important to be involved in treatment decision making. However, in a recent study it has been reported that about 40% of the participants experienced decision conflict and feel uninformed(1). The investigators therefore developed a patient decision aid (PDA) for stage I-II NSCLC patients, that informs and empowers patients to help decide between stereotactic radiotherapy (SBRT) and surgery.

Conditions

  • Lung Cancer Stage I
  • Lung Cancer Stage II

Interventions

OTHER

Patient Decision Aid

More than 20 IT specialists, 15 doctors and 15 patients

Sponsors & Collaborators

  • Maastricht University

    lead OTHER

Eligibility

Min Age
21 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-04
Primary Completion
2022-01-31
Completion
2022-02-28

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04375566 on ClinicalTrials.gov